Hydrogen Sulfide and Carbonyl Sulfide Delivery for Biological Applications
用于生物应用的硫化氢和硫化羰输送
基本信息
- 批准号:10683153
- 负责人:
- 金额:$ 32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAlginatesAnimal ModelAnimalsAttentionBiologicalBiological ModelsBiologyBlood VesselsBone RegenerationCell Culture TechniquesCell modelChemicalsDefectDiseaseEngineeringEnzymesFamilyFemurFutureGelGoalsHealthHumanHydrogen SulfideHydrolysisIndividualInvestigationKnowledgeLocalesLongevityMeasuresMetabolismMethodologyMethodsMissionModelingOsteoclastsOsteogenesisOutcomePlayProtein IsoformsPublic HealthRattusReproducibilityResearchResearch PersonnelRoleSignaling MoleculeStimulusSulfidesSulfurSystemTechnologyTherapeuticTissuesUnited States National Institutes of HealthUp-RegulationWorkbiological adaptation to stressbonecarbonate dehydratasecellular targetingdesigndisabilityexperimental studyimmune functionin vivoin vivo Modelinnovationinsightnovel strategiesosteogenicprotective effectrecruitregeneration modelthioestertissue regenerationtool
项目摘要
Project Summary
Hydrogen sulfide (H2S) plays important roles in human health ranging from vascular biology to tissue
regeneration. To advance investigations into roles, researchers often use H2S donors to directly modulate sulfide
levels during experiments. Despite this broad utility, key unmet needs remain that will be addressed in this
proposal. The long-term goal of this research is to develop and deploy COS/H2S donors to investigate and
advance the multifaceted roles of reactive sulfur species related to human health. The overall objectives of this
proposal are to broaden the platform of COS/H2S releasing motifs, to understand how different CA isoforms
impact COS to H2S conversion, and to apply COS/H2S donors to in vivo models of bone regeneration. The
rationale for these studies is that the functional tools for COS/H2S delivery and a greater understanding of
differential CA isoform activity toward COS hydrolysis will enable future applications in which COS/H2S release
is targeted to systems where key CA isoforms are present and H2S is known to play a protective effect. The
proposed investigations include three specific aims: (1) Expansion, refinement, and application of COS/H2S
releasing platforms; (2) Investigation in to the differential CA isoform activity toward COS hydrolysis; and (3)
Application of COS/H2S donors to bone regeneration. This proposal builds from prior work establishing that COS
releasing molecules can function as H2S donors due to the rapid enzymatic conversion of COS to H2S by
carbonic anhydrase (CA). In Aim 1, new chemical approaches are used to enable COS/H2S delivery, expand the
dynamic range and palette of traceable COS/H2S donors, and provide amplified release. In Aim 2, the hydrolytic
activity of individual CA isoforms toward COS and model thioester/thionoester substrates are investigated to
understand isoform differences in CA efficiency toward COS hydrolysis. In Aim 3, the developed COS/H2S
donors are used to investigate the role of H2S in cell and animal models of bone regeneration. This approach is
innovative because it provides new approaches to COS/H2S delivery that address key unmet needs in the field
and provides the first insights into the differential activity of CA isoforms for COS to H2S conversion. Moreover,
the proposed applications in bone regeneration are innovative because they not only leverage the protective
effects of H2S and high local activity of CA during osteogenesis, but also leverages the underutilized connection
of H2S with Ca2+ recruitment in osteoclasts. The proposed research is significant because it provides new
approaches that directly address key limitations in the field, including amplified release systems, trackable
donors, and analyte replacement methodologies. In addition, the proposed research provides the first insights
into CA isoform differences for COS to H2S conversion, which will be leveraged in model systems relevant to
human health in which both CA activity and H2S delivery are important. Successful completion of the proposed
Aims will provide a positive impact in the field of H2S biology and will result a greater understanding of the roles
of COS/H2S in human health.
项目摘要
硫化氢(H2S)在人类健康中起重要作用,从血管生物学到组织
再生。为了推进对角色的研究,研究人员经常使用H2S供体直接调节硫化物
实验中的水平。尽管有这种广泛的效用,但仍将解决的关键未满足需求将在此解决
提议。这项研究的长期目标是开发和部署COS/H2S捐助者来调查和
推进与人类健康有关的反应性硫种类的多方面作用。总体目标
建议将扩大COS/H2S释放图案的平台,以了解不同的CA同工型
对H2S转化的影响,并将COS/H2S供体应用于骨再生的体内模型。这
这些研究的理由是COS/H2S交付的功能工具以及对
差异Ca同工型对COS水解的活性将实现COS/H2S释放的未来应用
针对存在关键的CA同工型的系统,并且已知H2S具有保护作用。这
拟议的调查包括三个具体目的:(1)COS/H2S的扩展,改进和应用
释放平台; (2)研究对CO水解的差异Ca同工型活性; (3)
将COS/H2S供体应用于骨再生。该建议是由先前的工作建立的,确定了COS
释放分子可以作为H2S供体起作用,因为COS迅速转化为H2S
碳酸酐酶(CA)。在AIM 1中,使用新的化学方法来启用cos/h2s交付,扩展
可追溯COS/H2S供体的动态范围和调色板,并提供放大的释放。在AIM 2中,水解
研究了单个CA同工型对COS和模型硫酯/Thionoester底物的活性。
了解CA效率在COS水解方面的同工型差异。在AIM 3中,开发的cos/h2s
供体用于研究H2S在骨再生的细胞和动物模型中的作用。这种方法是
创新性,因为它提供了cos/h2s交付的新方法,以解决现场未满足的关键需求
并为CO与H2S转换的CA同工型的差异活动提供了第一个见解。而且,
提议的骨骼再生应用具有创新性,因为它们不仅利用了保护性
H2S和成骨过程中CA的高局部活动的影响,但也利用了未充分利用的连接
在破骨细胞中具有Ca2+募集的H2S的。拟议的研究很重要,因为它提供了新的
直接解决该领域关键限制的方法,包括放大的释放系统,可跟踪
捐助者和分析物替代方法。此外,拟议的研究提供了第一个见解
进入CO与H2S转换的CA同工型差异,该差异将在与
CA活动和H2S分娩都很重要的人类健康。成功完成拟议的
目标将在H2S生物学领域产生积极的影响,并将对角色有更深入的了解
人类健康中的cos/h2s。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Pluth其他文献
Michael Pluth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Pluth', 18)}}的其他基金
Hydrogen Sulfide and Carbonyl Sulfide Delivery for Biological Applications
用于生物应用的硫化氢和硫化羰输送
- 批准号:
10474265 - 财政年份:2015
- 资助金额:
$ 32万 - 项目类别:
Chemical Tools for Delivery and Detection of Biological Hydrogen Sulfide
用于输送和检测生物硫化氢的化学工具
- 批准号:
9330883 - 财政年份:2015
- 资助金额:
$ 32万 - 项目类别:
Hydrogen Sulfide and Carbonyl Sulfide Delivery for Biological Applications
用于生物应用的硫化氢和硫化羰输送
- 批准号:
10796675 - 财政年份:2015
- 资助金额:
$ 32万 - 项目类别:
Developing fluorescent probes for the endogenous gaseous transmitters NO and H2S
开发内源性气体递质 NO 和 H2S 荧光探针
- 批准号:
8054794 - 财政年份:2010
- 资助金额:
$ 32万 - 项目类别:
Developing fluorescent probes for the endogenous gaseous transmitters NO and H2S
开发内源性气体递质 NO 和 H2S 荧光探针
- 批准号:
8538454 - 财政年份:2010
- 资助金额:
$ 32万 - 项目类别:
Developing fluorescent probes for the endogenous gaseous transmitters NO and H2S
开发内源性气体递质 NO 和 H2S 荧光探针
- 批准号:
8333986 - 财政年份:2010
- 资助金额:
$ 32万 - 项目类别:
Developing fluorescent probes for the endogenous gaseous transmitters NO and H2S
开发内源性气体递质 NO 和 H2S 荧光探针
- 批准号:
7872197 - 财政年份:2010
- 资助金额:
$ 32万 - 项目类别:
Developing fluorescent probes for the endogenous gaseous transmitters NO and H2S
开发内源性气体递质 NO 和 H2S 荧光探针
- 批准号:
8323691 - 财政年份:2010
- 资助金额:
$ 32万 - 项目类别:
Fluorescence Sensing of NO: Development of Reversible Sensors Using Fe(III)
NO 的荧光传感:使用 Fe(III) 开发可逆传感器
- 批准号:
7778248 - 财政年份:2008
- 资助金额:
$ 32万 - 项目类别:
Fluorescence Sensing of NO: Development of Reversible Sensors Using Fe(III)
NO 的荧光传感:使用 Fe(III) 开发可逆传感器
- 批准号:
7538765 - 财政年份:2008
- 资助金额:
$ 32万 - 项目类别:
相似国自然基金
磷酸盐耦合作用下亨氏马尾藻砷吸收、转运和形态分布的过程研究
- 批准号:42377231
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
河口悬浮颗粒中异养细菌同化硝酸盐的驱动机制与抑藻效应
- 批准号:32370113
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
硝化应激在微囊藻毒素联合亚硝酸盐暴露诱导血-卵泡屏障破坏致卵巢早衰中的作用及分子机制
- 批准号:82273594
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
剩余污泥胞外聚合物中类藻酸盐物质结构及阻燃特性分析研究
- 批准号:52200033
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
硝化应激在微囊藻毒素联合亚硝酸盐暴露诱导血-卵泡屏障破坏致卵巢早衰中的作用及分子机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Islet dosing and loading density in injection molded macroencapsulation devices
注塑宏观封装装置中的胰岛剂量和装载密度
- 批准号:
10716174 - 财政年份:2023
- 资助金额:
$ 32万 - 项目类别:
Sprayable Hydrogel Barrier for the Delivery of Adhesion-Preventing Therapeutics
用于提供防粘连治疗的可喷雾水凝胶屏障
- 批准号:
10696561 - 财政年份:2023
- 资助金额:
$ 32万 - 项目类别:
Developing Therapeutic Gel Embolic Agents for Arteriovenous Malformation Embolization
开发用于动静脉畸形栓塞治疗的凝胶栓塞剂
- 批准号:
10667726 - 财政年份:2023
- 资助金额:
$ 32万 - 项目类别:
Extracellular Matrix Impacts Angiogenesis and Growth Plate Repair
细胞外基质影响血管生成和生长板修复
- 批准号:
10668056 - 财政年份:2023
- 资助金额:
$ 32万 - 项目类别:
Engineering microscale hydrogel deposition to direct single stem cell differentiation
工程微型水凝胶沉积指导单干细胞分化
- 批准号:
10370437 - 财政年份:2021
- 资助金额:
$ 32万 - 项目类别: